PHAXIAM Therapeutics S.A. — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

€194.0K

Net Income/Loss (FY2022)

-€228.0K

Total Assets (FY2022)

€45.8M

Total Equity (FY2022)

€23.5M

Cash Flows from Operating Activities (FY2022)

-€31.8M

Source: PHAXIAM Therapeutics S.A. 20-F filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.